On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
Bleeding on the battlefield and in routine surgery is controlled by a number of different products, all of which have drawbacks, such as the potential for excessive heat, blood clots and allergic reactions. But a new biodegradable protein solution able to stanch bleeding in mere seconds appears to also be nontoxic and long-lasting in animals. Researchers at the Massachusetts Institute of Technology and the University of Hong Kong developed a liquid made from short proteins, or peptides, that could repair severed optic nerves in hamsters and control brain bleeding in mice, as well as oozing from other types of wounds. The liquid apparently formed a fibrous network over the wound that stopped bleeding, although how the material works in detail is unclear. The liquid does not seem to form a conventional blood clot, the group notes in a study published online October 10 in Nanomedicine.
Subscribe to Support Independent Journalism
Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.
When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.
Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber
